Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D (2008) Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 14(35):5377–5384

PubMed  PubMed Central  Google Scholar 

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31(12):1770–1786

PubMed  PubMed Central  Google Scholar 

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA et al (2022) Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 33(1):115–154

CAS  PubMed  Google Scholar 

Clift AK, Kidd M, Bodei L, Toumpanakis C, Baum RP, Oberg K et al (2020) Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology 110(6):444–476

CAS  PubMed  Google Scholar 

Massironi S (2024) The diagnostic challenges of functioning neuroendocrine tumors: balancing accuracy, availability, and personalized care. Expert Rev Endocrinol Metab 19(2):99–101

CAS  PubMed  Google Scholar 

Das S, Dasari A, Epidemiology (2021) Incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep 23(4):43

PubMed  PubMed Central  Google Scholar 

Lee MR, Harris C, Baeg KJ, Aronson A, Wisnivesky JP, Kim MK (2019) Incidence trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States. Clin Gastroenterol Hepatol 17(11):2212–7e1

PubMed  Google Scholar 

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3(10):1335–1342

PubMed  PubMed Central  Google Scholar 

Thiis-Evensen E, Boyar Cetinkaya R (2023) Incidence and prevalence of neuroendocrine neoplasms in Norway 1993–2021. J Neuroendocrinol 35(4):e13264

CAS  PubMed  Google Scholar 

Michael M, Thursfield V, Te Marvelde L, Kong G, Hicks RJ (2022) Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: based on site, grade, and region. Asia Pac J Clin Oncol 18(5):e306–e17

CAS  PubMed  Google Scholar 

Xu Z, Wang L, Dai S, Chen M, Li F, Sun J et al (2021) Epidemiologic trends of and factors Associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw Open 4(9):e2124750

PubMed  PubMed Central  Google Scholar 

Rossi RE, Massironi S (2022) The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues. J Clin Med. 11. Switzerland

Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R et al (2022) Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study. J Endocrinol Invest 45(4):849–857

CAS  PubMed  Google Scholar 

Imbroisi Filho R, Ochioni AC, Esteves AM, Leandro JGB, Demaria TM, Sola-Penna M et al (2021) Western diet leads to aging-related tumorigenesis via activation of the inflammatory, UPR, and EMT pathways. Cell Death Dis 12(7):643

CAS  PubMed  PubMed Central  Google Scholar 

Muscogiuri G, Barrea L, Cantone MC, Guarnotta V, Mazzilli R, Verde L et al (2022) Neuroendocrine tumors: a Comprehensive Review on Nutritional approaches. Cancers (Basel) 14:18

Google Scholar 

Mentella MC, Scaldaferri F, Ricci C, Gasbarrini A, Miggiano GAD (2019) Cancer Mediterranean Diet: Rev Nutrients. ;11(9)

Maasberg S, Knappe-Drzikova B, Vonderbeck D, Jann H, Weylandt KH, Grieser C et al (2017) Malnutrition predicts clinical outcome in patients with neuroendocrine neoplasia. Neuroendocrinology 104(1):11–25

CAS  PubMed  Google Scholar 

Clement D, van Leerdam ME, Tesselaar MET, Cananea E, Martin W, Weickert MO et al (2024) The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours. J Neuroendocrinol. :e13376

Clement D, Leerdam MEV, de Jong S, Weickert MO, Ramage JK, Tesselaar MET et al (2023) Prevalence of Sarcopenia and Impact on Survival in patients with metastatic gastroenteropancreatic neuroendocrine tumours. Cancers (Basel). ;15(3)

Clement D, Brown S, Leerdam MV, Tesselaar M, Ramage J, Srirajaskanthan R (2024) Sarcopenia and Neuroendocrine Neoplasms. Curr Oncol Rep 26(2):121–128

PubMed  Google Scholar 

Capuozzo M, Celotto V, Landi L, Ferrara F, Sabbatino F, Perri F et al (2023) Beyond body size: Adiponectin as a key player in obesity-driven cancers. Nutr Cancer 75(10):1848–1862

PubMed  Google Scholar 

Wells GA SB, O’Connell D The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa: Ottawa Hospital Research Institute. p. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A et al (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18(10):2127–2133

PubMed  Google Scholar 

Clement DS, Tesselaar ME, van Leerdam ME, Srirajaskanthan R, Ramage JK (2019) Nutritional and vitamin status in patients with neuroendocrine neoplasms. World J Gastroenterol 25(10):1171–1184

CAS  PubMed  PubMed Central  Google Scholar 

Barrea L, Altieri B, Muscogiuri G, Laudisio D, Annunziata G, Colao A et al (2018) Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness. Nutrients. ;10(12)

Gallo M, Muscogiuri G, Pizza G, Ruggeri RM, Barrea L, Faggiano A et al (2019) The management of neuroendocrine tumours: a nutritional viewpoint. Crit Rev Food Sci Nutr 59(7):1046–1057

PubMed  Google Scholar 

Qureshi SA, Burch N, Druce M, Hattersley JG, Khan S, Gopalakrishnan K et al (2016) Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study. BMJ Open 6(5):e010765

PubMed  PubMed Central  Google Scholar 

Borre M, Dam GA, Knudsen AW, Grønbaek H (2018) Nutritional status and nutritional risk in patients with neuroendocrine tumors. Scand J Gastroenterol 53(3):284–292

PubMed  Google Scholar 

Pavel M, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP et al (2018) Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocr Relat Cancer 25(3):309–322

CAS  PubMed  PubMed Central  Google Scholar 

Romano E, Polici M, Marasco M, Lerose F, Dell’Unto E, Nardacci S et al (2024) Sarcopenia in patients with Advanced Gastrointestinal Well-differentiated neuroendocrine tumors. Nutrients. ;16(14)

Herrera-Martínez Y, Alzas Teomiro C, León Idougourram S, Molina Puertas MJ, Calañas Continente A, Serrano Blanch R et al (2021) Sarcopenia and Ghrelin System in the clinical outcome and prognosis of gastroenteropancreatic neuroendocrine neoplasms. Cancers (Basel). ;14(1)

Kessinger A, Lemon HM, Foley JF (1977) The glucagonoma syndrome and its management. J Surg Oncol 9(5):419–424

CAS  PubMed  Google Scholar 

Rinzivillo M, De Felice I, Magi L, Annibale B, Panzuto F (2020) Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs. Pancreatology 20(5):875–879

CAS  PubMed  Google Scholar 

Lamarca A, McCallum L, Nuttall C, Barriuso J, Backen A, Frizziero M et al (2018) Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study. Expert Rev Gastroenterol Hepatol 12(7):723–731

CAS  PubMed  Google Scholar 

Marrache F, Vullierme MP, Roy C, El Assoued Y, Couvelard A, O’Toole D et al (2007) Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer 96(1):49–55

CAS  PubMed  Google Scholar 

Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B (2008) Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 14(23):7798–7803

CAS  PubMed  Google Scholar 

Lind A, Wängberg B, Ellegård L (2016) Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET). Eur J Clin Nutr 70(9):990–994

CAS  PubMed  Google Scholar 

Chan DL, Clarke SJ, Engel A, Diakos CI, Pavlakis N, Roach PJ et al (2022) Computed tomography (CT)-defined Sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT). Eur J Clin Nutr 76(1):143–149

CAS  PubMed  Google Scholar 

Budek M, Nuszkiewicz J, Piórkowska A, Czuczejko J, Szewczyk-Golec K (2022) Inflammation related to obesity in the etiopathogenesis of gastroenteropancreatic neuroendocrine neoplasms. Biomedicines. ;10(10)

Santos AP, Santos AC, Castro C, Raposo L, Pereira SS, Torres I et al (2018) Visceral obesity and metabolic syndrome are Associated with Well-differentiated gastroenteropancreatic neuroendocrine tumors. Cancers (Basel). ;10(9)

Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112(12):1785–1788

CAS  PubMed  PubMed Central  Google Scholar 

Kim JW, Kim JH, Lee YJ (2024) The role of Adipokines in Tumor Progression and its association with obesity. Biomedicines. ;12(1)

Lan X, Fazio N, Abdel-Rahman O (2022) Exploring the relationship between obesity, metabolic syndrome and neuroendocrine neoplasms. Metabolites. ;12(11)

Tschann P, Weigl MP, Clemens P, Szeverinski P, Attenberger C, Kowatsch M et al (2023) Sarcopenic obesity is a risk factor for worse Oncological Long-Term Outcome in locally advanced rectal Cancer patients: a retrospective single-Center Cohort Study. Nutrients. ;15(11)

Massironi S, Zilli A, Bernasconi S, Fanetti I, Cavalcoli F, Ciafardini C et al (2017) Impact of vitamin D on the clinical outcome of gastro-entero-pancreatic neuroendocrine neoplasms: report on a series from a single Institute. Neuroendocrinology 105(4):403–411

CAS  PubMed  Google Scholar 

Robbins HL, Symington M, Mosterman B, Goodby J, Davies L, Dimitriadis GK et al (2018) Supplementation of vitamin D Deficiency in patients with neuroendocrine tumors using over-the-counter vitamin D3 preparations. Nutr Cancer 70(5):748–754

CAS  PubMed  Google Scholar 

Albertelli M, Petolicchio C, Brasili S, Pogna A, Boschetti M, Luciano G et al (2023) Impact of vitamin D Deficiency on Tumor aggressiveness in neuroendocrine neoplasms. Nutrients. ;15(17)

Shah GM, Shah RG, Veillette H, Kirkland JB, Pasieka JL, Warner RR (2005) Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol 100(10):2307–2314

CAS  PubMed